We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVXL icon
2126
Anavex Life Sciences
AVXL
$310M
$20K ﹤0.01%
+5,049
New +$18K
BGFV
2127
DELISTED
Big 5 Sporting Goods
BGFV
$20K ﹤0.01%
+1,173
New +$20.6K
BLBD icon
2128
Blue Bird Corp
BLBD
$2.18B
$20K ﹤0.01%
1,284
+906
+240% +$14.1K
CALM icon
2129
Cal-Maine
CALM
$3.99B
$20K ﹤0.01%
+442
New +$17.6K
CASH icon
2130
Pathward Financial
CASH
$1.8B
$20K ﹤0.01%
+570
New +$15.9K
COKE icon
2131
Coca-Cola Consolidated
COKE
$12.8B
$20K ﹤0.01%
+1,150
New +$18K
EVTC icon
2132
Evertec
EVTC
$1.78B
$20K ﹤0.01%
+1,117
New +$18.5K
FAS icon
2133
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
$20K ﹤0.01%
477
-33,570
-99% -$1.16M
FONR
2134
DELISTED
Fonar
FONR
$20K ﹤0.01%
1,023
+653
+176% +$12.7K
FSP
2135
Franklin Street Properties
FSP
$46.8M
$20K ﹤0.01%
+1,570
New +$19K
GKOS icon
2136
Glaukos
GKOS
$10.6B
$20K ﹤0.01%
+569
New +$19.5K
HFWA icon
2137
Heritage Financial
HFWA
$1.21B
$20K ﹤0.01%
+770
New +$16.5K
INGR icon
2138
Ingredion
INGR
$6.58B
$20K ﹤0.01%
164
-2,508
-94% -$317K
INSW icon
2139
International Seaways
INSW
$4.57B
$20K ﹤0.01%
+1,451
New +$19.5K
IVR icon
2140
Invesco Mortgage Capital
IVR
$805M
$20K ﹤0.01%
136
-41
-23% -$6.08K
LGND icon
2141
Ligand Pharmaceuticals
LGND
$6.36B
$20K ﹤0.01%
313
+133
+74% +$8.39K
MGNI icon
2142
Magnite
MGNI
$3.55B
$20K ﹤0.01%
2,677
+2,377
+792% +$18.5K
MOV icon
2143
Movado Group
MOV
$841M
$20K ﹤0.01%
+682
New +$17.6K
NFBK
2144
DELISTED
Northfield Bancorp
NFBK
$20K ﹤0.01%
+1,034
New +$18.5K
NNVC icon
2145
NanoViricides
NNVC
$36.2M
$20K ﹤0.01%
935
+438
+88% +$11.7K
PDS
2146
Precision Drilling
PDS
$974M
$20K ﹤0.01%
+137
New +$13.5K
PMT
2147
PennyMac Mortgage Investment
PMT
$842M
$20K ﹤0.01%
1,200
+189
+19% +$2.99K
RRR icon
2148
Red Rock Resorts
RRR
$3.62B
$20K ﹤0.01%
+875
New +$19.9K
SAND
2149
DELISTED
Sandstorm Gold
SAND
$20K ﹤0.01%
3,900
-15,882
-80% -$66.5K
SLS icon
2150
SELLAS Life Sciences
SLS
$2.36B
$20K ﹤0.01%
+7
New +$40.7K
84 85
86
87 88

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.